Modifying PEST for Psoriatic Arthritis Screening

Key Who May Qualify: 1. Moderate-to-severe plaque PsO patients who are candidates for bDMARDs, as per provincial reimbursement criteria 2. Adult patients at the time of willing to sign a consent form signature 3. Patients able to understand and willing to comply with protocol requirements, instructions, and restrictions 4. Residents of Canada Key Who Should NOT Join This Trial: 1. Patients who have previously screened positive for PsA through PEST or any other screening method 2. Patients who have been diagnosed with PsA and/or followed by a rheumatologist 3. Patients who have been diagnosed with inflammatory arthritis unrelated to PsA (rheumatoid arthritis, reactive arthritis, enteropathic arthritis, axial spondyloarthritis) 4. Patients treated with a bDMARD for moderate-to-severe plaque PsO or any other medical condition Always talk to your doctor about whether this trial is right for you.